were studied. All five type B strains produced both 16S (large or L) and 12S (medium or M) toxins, although the relative amounts varied with the strains. The culture supernatant of type B Okra strain was the most potent in oral toxicity. The L toxin of this culture was about 700 times more toxic in feeding tests with mice than the L toxin from type B strain NH-2, whereas the M toxins of the two strains had the same oral toxicity. These results indicate that the oral toxicity of type B toxin varies with the culture strain. Oral toxicities of L toxin produced by type A strains 62A and 97 were comparable but were 10 times higher than those of their M toxins. Hybrids of toxic and nontoxic components separated from L toxins of type B strains Okra and NH-2 revealed that the high oral toxicity of the B-L toxin of strain Okra is attributable not to the toxic but to the nontoxic component of the toxin. The present study suggests that the 16S molecular-sized toxin elaborated by a certain strain of C. botulinum type B is implicated in the high fatality rate in type B human botulism.
The production and the oral toxicity for mice of Clostridium botulinum type A and B toxins of different strains were studied. All five type B strains produced both 16S (large or L) and 12S (medium or M) toxins, although the relative amounts varied with the strains. The culture supernatant of type B Okra strain was the most potent in oral toxicity. The L toxin of this culture was about 700 times more toxic in feeding tests with mice than the L toxin from type B strain NH-2, whereas the M toxins of the two strains had the same oral toxicity. These results indicate that the oral toxicity of type B toxin varies with the culture strain. Oral toxicities of L toxin produced by type A strains 62A and 97 were comparable but were 10 times higher than those of their M toxins. Hybrids of toxic and nontoxic components separated from L toxins of type B strains Okra and NH-2 revealed that the high oral toxicity of the B-L toxin of strain Okra is attributable not to the toxic but to the nontoxic component of the toxin. The present study suggests that the 16S molecular-sized toxin elaborated by a certain strain of C. botulinum type B is implicated in the high fatality rate in type B human botulism.
Food-borne botulism is a highly fatal disease which results from the ingestion of the potent neurotoxin produced by Clostridium botulinum in food. Although the occurrence of the disease is governed by a number of factors, the stability of the ingested toxin in the digestive tract is one of the pathophysiologically significant factors for the onset of the disease. C. botulinum cultures produce toxins of different molecular sizes: 19, 16, and 12S for type A (16); 16 and 12S for types B, C, and D (6, 8, 11) ; 12S for type E (5); and 10S for type F (9). All these toxins are complexes of a toxic component of 5-7S with a nontoxic component of the same or larger molecular size. These complexed toxins are more stable than their respective toxic components (5, 6, 8, 9, 11, 16) , so that the oral toxicities of 10-19S complexes of the toxins are higher than those of the purified toxic components (11, 12) . The high stability of the complex form of botulinum toxin in gastric and intestinal juices correlates with the high absorption rate of the toxin from the intestine and consequently with the high oral toxicity (11, 12, 14, 15) . Among botulinum type A through F toxins, a type B toxin of 16S, L toxin (large molecular-sized toxin), purified from C. botulinum type B strain Okra, is highly resistant to gastric and intestinal juices (14) and has exceptionally potent oral toxicity for mice (12) ; its oral toxicity is 100 times higher than those of 10-12S botulinum toxins, M toxins (medium molecular-sized toxins), of all C. botulinum cultures tested to date. The high oral toxicity of type B-L toxin for mice, however, is not correlated with the fatality rate of type B food-borne botulism; in the United States from 1950 to 1979, the fatality rate of type B food-borne botulism was 8.8%, whereas those of types A and E were 24.3 and 30.8%, respectively (2) . This apparent discrepancy would be partly explained if all C. botulinum type B strains do not produce a significant amount of L toxin, or toxins produced by different strains vary in their oral toxicities.
In the present study, these possibilities were examined by comparing several C. botulinum type A and B culture strains for the production and the oral toxicity of different molecular sizes. All type B strains examined produce both L and M toxins, but the L toxin elaborated by type B strain Okra differed in its extremely high oral toxicity in mice.
MATERIALS AND METHODS
Bacterial strains. C. botulinum type A strains 97 and 62A and type B strains Okra, NH-2, NIH, 169B, and QC were used. Type B strains 169B and NIH were provided by K. Oguma, Hokkaido University, Sapporo, Japan.
Toxin production and purification. Toxin production medium was 0.5% glucose-0.5% yeast extract-2.0% peptone-0.05% L-cysteine hydrochloride (pH 7.3) (9). After incubation for 3 days at 30°C, the culture supernatant was obtained by centrifugation for 20 min at 7,800 x g. The toxin concentrate was prepared by adding 86 g of ammonium sulfate to 200 ml of culture fluid and extracting with 10 ml of 0.2 M phosphate buffer (pH 6.0). The extract was dialyzed against 0.05 M acetate buffer (pH 6.0), and the insoluble material was removed by centrifugation for 20 min at 7,800 x g. C. botulinum type A and B toxins were purified by essentially the same procedures as those employed for purification of type F toxin (9, 10).
Determination of intraperitoneal and oral toxicities. Male mice (strain ddY-S), weighing 18 to 24 g, were used. Serial twofold dilutions of toxin sample were made in 0.05 M phosphate buffer (pH 6.0) containing 0.1% gelatin, and the intraperitoneal mean lethal dose (i.p. LD50) was determined by injecting 0.2 ml of a given dilution intraperitoneally into separate groups of five mice so as to cover 100 to 0% death rates. The oral administration to mice was performed as described previously (12) . The intraperitoneal and the oral 50% lethal doses were calculated by the method of Reed and Muench (13) from deaths within 5 days. The oral toxicity was expressed as the number of i.p. LD50s.
The toxicities of fractions obtained by ultracentrifugation were determined by the time-to-death method (1 (Fig.  1) .
Oral toxicities of different molecular-sized toxins. Toxins of type A strains 97 and 62A and type B strains Okra and NH-2 were purified, and the oral toxicities of the toxins of different molecular sizes were compared ( Table 2 ). The oral toxicity of the L toxin of strain Okra was 714 times higher than that of the L-toxin of strain NH-2, whereas those of M toxins of both these strains were of the same order; the oral toxicities of the L and M toxins of strain NH-2 were of the same order. Oral toxicities of the L toxins of type A strains 97 and 62A
were similar, as were those of the M toxins of the cultures; the oral toxicities of the L toxins from these strains were about 10 times higher than those of the M toxins. Oral toxicities of hybrid toxins. Toxic and nontoxic components separated from the L toxin of type B strain Okra were reconstituted with those from the L toxin of strain NH-2 to determine whether the higher oral toxicity of type B-L toxin of strain Okra is attributable to the toxic or the nontoxic component. Although the toxic and nontoxic components were mixed at a protein ratio of 1:3, ultracentrifugal analysis of the hybrid toxin prepared showed the presence of a 16S molecular-sized toxin (Fig. 2) . The oral toxicity of the hybrid toxin formed between the toxic component of strain NH-2 and the nontoxic component of strain Okra was almost the same as that between the toxic and nontoxic components of strain Okra, although the latter hybrid toxin showed about three times lower oral toxicity than that of the original L toxin of strain Okra (Table 3) . On the other hand, the toxin hybridized between the toxic component of strain Okra and the nontoxic component of strain NH-2 was of the same order in oral toxicity as that between the toxic and nontoxic components of strain NH-2. The oral toxicity of hybridized toxin between the toxic and nontoxic components of strain NH-2 was also of the same order as that of the original L toxin of strain NH-2.
DISCUSSION
The present results show that the oral toxicity of type B-L toxin is not always extremely high. Among the five type B strains examined, strain Okra produced an L toxin of higher than average oral toxicity. Ultracentrifugal analysis of the concentrates of the culture supernatants showed that all type B strains produced both L and M toxins. These results indicate that the difference in the oral toxicity of the culture supernatant between type B strain Okra and the others is not due to the absence of the 16S molecular-sized toxin but to the lower oral toxicity of the toxin produced by the latter strains. This was further confirmed with the purified toxins of different molecular sizes of strains Okra and NH-2; the purified B-L toxin of strain Okra exerted more potent oral toxicity to mice than that of strain NH-2, whereas the oral toxicities of the M toxins from both strains were approxi- by strain Okra is not due to the high parenteral toxicity of the toxin but possibly to the high stability and consequently to the high absorption rate of the toxin in the intestine (11, 14, 15) . Hybridization tests between the toxic and nontoxic components of type B-L toxins also support this explanation. The results showed that the high oral toxicity of the L toxin of strain Okra is attributable to the nontoxic component, which plays a role in protecting the toxic component from destruction by gastric and intestinal juices in the digestive tract (14, 15) . This suggests that the oral toxicity of type B-L toxin is dependent on the molecular conformation assembled with toxic and nontoxic components.
The L toxins purified from type A strains 62A and 97 showed approximately the same oral toxicity, which corresponds to that of the L toxin produced by C. botulinum type A strain Hall (12) , whereas the oral toxicity of type A-L toxin was about 10 times higher than that of the M toxin. Previous studies have demonstrated that the L toxins purified from three different strains of C. botulinum types C and D have the same toxicity when administered orally to mice (11) . Therefore, it seems likely that the oral toxicities of the L toxins of C. botulinum types A, C, and D do not vary from one strain to another, whereas that of the L toxin produced by C. botulinum type B varies with the strain. It is not yet known whether C. botulinum type B strains other than strain Okra produce L toxin of an extremely high oral toxicity corresponding to that of strain Okra.
Human food-borne botulism is mainly caused by C. botulinum type A, B, and E toxins. Previous studies have shown that, among type A, B, C, and D toxins of different molecular sizes, type B-L toxin produced by strain Okra is the most potent in oral toxicity to mice (11, 12) . The toxin is produced not only in laboratory media but also in foodstuffs (17) . Moreover, the present study demonstrated that B-L toxin is produced by all strains of C. botulinum type B examined. Therefore, it seems possible that B-L toxin is implicated in human type B botulism. However, it has been reported that the average case fatality rate of human type B botulism is not significantly higher than that of type A botulism and that type B botulism is less severe than type A botulism (3, 4) . The present study demonstrated that type B-L toxin of different cultures varies in oral toxicity and that the oral toxicity of A-L toxin is about 10 times higher than those of L and M toxins produced by type B strains other than Okra. This may partly explain the discrepancy between the previously reported high oral toxicity of B-L toxin in mice and the clinical fatality rate or the severity of type B botulism. It is possible that a certain type B botulism results in a high fatality rate, if it is caused by the L toxin produced by C. botulinum type B strain Okra or the corresponding strains.
